SYSGenomics Overview
- Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
SYSGenomics General Information
Description
Developer of molecular diagnostic tests intended for cancer patients. The company's platform is a molecular diagnostic test, enabling cancer patients and their oncologists to select treatment strategies.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Primary Office
- 51210 Lexingham Drive
- Granger, IN 46530
- United States
+1 (574) 000-0000
SYSGenomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Jan-2023 | Completed | Startup | |||
| 1. Accelerator/Incubator | 03-Aug-2015 | Completed | Startup |
SYSGenomics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Steven Buechler Ph.D | Co-Founder | ||
| Sunil Badve MD | Co-Founder | ||
| Yesim Gökmen-Polar Ph.D | Co-Founder |